drug discovery Twist Bioscience Reports 17 Percent Growth of Fiscal Q4 Revenues, to Acquire Abveris The firm has entered into a definitive agreement to acquire Abveris, an antibody discovery company, for up to $190 million in stock and cash. Indivumed Launches Bioinformatics Platform, Expands Cancer Drug Discovery Efforts Premium The firm has revamped its business model to focus on AI-driven drug discovery and partnerships with pharma and academic cancer researchers. Syntegra Teams With Vanderbilt's Nashville Biosciences on Biobank Data Analysis for Drug R&D Data analysis firm Syntegra will work with NashBio to produce and validate synthetic data from the BioVU biobank, starting with type 2 diabetes. ERS Genomics Licenses CRISPR Patents to Nuvisan Nuvisan, based in Waltrop, Germany, will use ERS'w Genomics CRISPR-Cas9 portfolio to help advance its clients' drug discovery and early development programs. Enpicom, Viroclinics-DDL Expand Partnership to Accelerate Antibody, Vaccine Discovery A Dutch province has awarded an unspecified sum to the Netherlands-based firms to combine their technologies for TCR and BCR repertoire sequencing and analysis. Mar 30, 2021 Cleveland Clinic, IBM Partner on High-Performance Computing for Life Science, Healthcare Research Mar 18, 2021 Genialis Teams With Slovenian Bioinformatics Group to Develop Precision Medicine Tools Mar 17, 2021 M2Gen Lands New Private Investment, Inks Research Deal with Merck Mar 17, 2021 Genomics Plc Looks to Grow 'Genomic Prevention' With Polygenic Risk Scores Premium Mar 2, 2021 NIH, Partners Commit $74.9M to New Phase of Alzheimer's Program Feb 19, 2021 Cytosine Base Editors Allow Scientists to Study Function of Variants at Scale Premium Feb 19, 2021 Startup GATC Health Builds Predictive Multiomics Technology for Research, Patient Care Premium Jan 29, 2021 4HF Biotec Banking on Multiomic Data Analysis to Help Pharma Find New Oncology Compounds Premium Jan 7, 2021 Genuity Science, Emory Team on Biomarker Discovery for Neurodegenesis Dec 11, 2020 COVID-19 GWAS Leads to Immune Genes Linked to Severe Disease, Treatment Targets Nov 23, 2020 Broad Institute DepMap Project Could Lead to Development of New Cancer Drugs Premium Oct 29, 2020 Transcriptomics Data Suggest Existing Drugs Could Inhibit SARS-CoV-2 Premium Oct 7, 2020 Nvidia Expands Genomics Activities With Supercomputer, New Partnerships Premium Oct 1, 2020 Genuity Science, Ionis Pharmaceuticals Partner on Antisense Therapy Development Aug 4, 2020 Genuity Science Gains Access to BioVU With Nashville Biosciences Deal Jul 13, 2020 Genuity Science, Formerly WuXi NextCode, Reinvents Itself With US, Europe Focus Premium Jul 9, 2020 M2Gen Builds Cancer Research Database, Bets on Data Harmonization Premium Jul 1, 2020 Celsius Therapeutics Teams With Oxford, Cleveland Clinic, LMU on Single-Cell IBD Research Jun 11, 2020 Seven Bridges Building Research Platform for PanCAN Jun 10, 2020 10x Genomics, MilliporeSigma Collaborate on CRISPR Screening Workflow Load More Breaking News Variant Identified in Amish Population Appears to Protect From Cardiovascular Disease Danaher Prices $1B Offering of Senior Notes Discovery Life Sciences Acquires Contract Research Firm In Vitro ADMET Laboratories Audere Gets FDA Emergency Use Authorization for SARS-CoV-2 At-Home Sample Collection Kit GenomeWeb Index Falls 6 Percent in November as Emergence of Omicron Spooks Markets Sequencing-Based MRD Detection in Bone Marrow May Predict ALL Relapse After CAR T-Cell Therapy The Scan Science Confidence Boost The New York Times reports that a new poll finds trust in science and scientists has increased with the COVID-19 pandemic. Appeal and Funds Some grant applications denied funding due to an Australian Research Council rule change have now been funded following an appeal, the Guardian reports. Surveillance for Variants Vox writes that the detection of the Omicron SARS-CoV-2 variant highlights the need for improved viral genomic surveillance. Nature Papers Examine Taxonomic Gaps in Plant Sequencing, SARS-CoV-2-Human Interactome In Nature this week: plant genome sequencing dominated by affluent countries, and more.